Adaptive Biotechnologies is a biotechnology company specializing immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems.
Adaptive Biotechnologies does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.
The stock price for Adaptive Biotechnologies will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 1/4/2018 | Series F-1 | $1.35B | $XXX.XX | $XXX.XX |
| 5/6/2015 | Series F | $1.08B | $XXX.XX | $XXX.XX |
| 1/22/2015 | Series E1 | $652.13MM | $XXX.XX | $XXX.XX |
| 1/21/2015 | Series E | $321.37MM | $XXX.XX | $XXX.XX |
| 7/29/2014 | Series D | $261.89MM | $XXX.XX | $XXX.XX |
| 7/9/2013 | Series C | $76.08MM | $XXX.XX | $XXX.XX |
| 6/2/2011 | Series B | $49.04MM | $XXX.XX | $XXX.XX |
| 3/24/2010 | Series A | $27.52MM | $XXX.XX | $XXX.XX |
